NIS793

NIS-793 · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for NIS793, covering 2024-07-16 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: FOLFIRINOX + NIS793 in Pancreatic Cancer [Phase 1]